*The following content is generated by AI and is for reference only.
<h3>Overview</h3>
<p>Ranolazine is an antianginal agent used for chronic management of heart failure. Its core synthesis involves <strong>chemical reduction</strong> and purification steps to ensure high purity. The molecular formula is C<sub>18</sub>H<sub>24</sub>N<sub>2</sub>O<sub>3</sub> with CAS No. 146709-77-9.</p>
<h3>Application</h3>
<ul>
<li><strong>Pharmaceutical Industry:</strong> Production of extended-release tablets for angina pectoris treatment.</li>
<li><strong>Clinical Research:</strong> Investigating efficacy in reducing myocardial ischemia without affecting heart rate.</li>
</ul>
<h3>Precautions</h3>
<p>Strictly contraindicated with strong CYP3A4 inhibitors. Store in a cool, dry place below 25°C protected from light. Monitor QT interval prolongation risks during clinical use.</p>